108 related articles for article (PubMed ID: 5014613)
1. The effect of calcium and other salts upon the release of glucagon-like immunoreactivity from the gut.
Böttger I; Faloona GR; Unger RH
J Clin Invest; 1972 Apr; 51(4):831-6. PubMed ID: 5014613
[TBL] [Abstract][Full Text] [Related]
2. Chromatographic pattern of gut glucagon-like immunoreactivity (GLI) in plasma before and during glucose absorption.
Valverde I; Ghiglione M; Matesanz R; Casado S
Horm Metab Res; 1979 May; 11(5):343-6. PubMed ID: 478429
[TBL] [Abstract][Full Text] [Related]
3. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose.
Karmann H; Mialhe P
Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
[TBL] [Abstract][Full Text] [Related]
5. Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity.
Ohneda A; Horigome K; Kai Y; Itabashi H; Ishii S; Yamagata S
Horm Metab Res; 1976 May; 8(3):170-4. PubMed ID: 939462
[TBL] [Abstract][Full Text] [Related]
6. Characterization of response of gut GLI to fat ingestion in dogs.
Ohneda A; Kobayashi T; Nihei J
Horm Metab Res; 1984 Dec; 16 Suppl 1():105-9. PubMed ID: 6398248
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic glucagon-like immunoreactivity in a pancreatectomized patient.
Botha JL; Vinik AI; Child PT; Paul M; Jackson WP
Horm Metab Res; 1977 May; 9(3):199-205. PubMed ID: 885471
[TBL] [Abstract][Full Text] [Related]
8. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.
Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP
Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649
[TBL] [Abstract][Full Text] [Related]
9. The significance of plasma gastrointestinal glucagon in endotoxemia.
Ishida K
Circ Shock; 1985; 16(4):317-23. PubMed ID: 3836025
[TBL] [Abstract][Full Text] [Related]
10. Plasma glucagon-like immunoreactivity (GLI) in dogs.
Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
[TBL] [Abstract][Full Text] [Related]
11. The effects of triglyceride absorption upon glucagon, insulin, and gut glucagon-like immunoreactivity.
Böttger I; Dobbs R; Faloona GR; Unger RH
J Clin Invest; 1973 Oct; 52(10):2532-41. PubMed ID: 4738064
[TBL] [Abstract][Full Text] [Related]
12. Elevation of plasma glucagon-like immunoreactivity (GLI) in patients with liver cirrhosis.
Watanabe A; Hashimoto M; Higashi T; Kobayashi M; Nakatsukasa H; Yamauchi Y; Watanabe M; Fujiwara M; Nagashima H
J Med; 1986; 17(2):95-108. PubMed ID: 3473162
[TBL] [Abstract][Full Text] [Related]
13. Effect of intraluminal bile or bile acids on release of gut glucagon-like immunoreactive materials in the dog.
Namba M; Matsuyama T; Nonaka K; Tarui S
Horm Metab Res; 1983; 15(2):82-4. PubMed ID: 6826142
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of extractable gut glucagon-like immunoreactivity (GLI) and its lipolytic activity.
Horigome K; Oneda A; Maruhama Y; Abe R; Kai Y
Horm Metab Res; 1977 Sep; 9(5):370-4. PubMed ID: 924346
[TBL] [Abstract][Full Text] [Related]
15. Release of gut GLI by luminal hypotonicity.
Matsuyama T; Namba M; Shima K; Nonaka K; Tarui S
Horm Metab Res; 1981 Aug; 13(8):471-2. PubMed ID: 7327527
[No Abstract] [Full Text] [Related]
16. Regional release of glucagon-like immunoreactivity from the intestine of the cat.
Frame CM
Horm Metab Res; 1977 Mar; 9(2):117-20. PubMed ID: 863376
[TBL] [Abstract][Full Text] [Related]
17. The effect of phenformin upon the plasma pancreatic and gut glucagon-like immunoreactivity in diabetics.
Czyzyk A; Heding LG; Malczewski B; Miedzinska E
Diabetologia; 1975 Apr; 11(2):129-33. PubMed ID: 168107
[TBL] [Abstract][Full Text] [Related]
18. The effect of somatostatin on the response of GLI to the intraduodenal administration of glucose, protein, and fat.
Sakurai H; Dobbs RE; Unger RH
Diabetologia; 1975 Oct; 11(5):427-30. PubMed ID: 1181667
[TBL] [Abstract][Full Text] [Related]
19. Anomeric specificity in the response of gut glucagon-like immunoreactive materials to glucose.
Matsuyama T; Tanaka R; Shima K; Tarui S
Horm Metab Res; 1979 Mar; 11(3):214-6. PubMed ID: 447202
[TBL] [Abstract][Full Text] [Related]
20. The use of perfused rat intestine to characterise the glucagon-like immunoreactivity released into serosal secretions following stimulation by glucose.
O'Connor FA; Conlon JM; Buchanan KD; Murphy RF
Horm Metab Res; 1979 Jan; 11(1):19-23. PubMed ID: 428905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
